Alpha(1)-adrenergic receptor subtypes: non-identical triplets with different dancing partners?

Chris Hague1, Zhongjian Chen, Michelle Uberti

  • 1Department of Pharmacology, Emory University, Atlanta, GA 30322, USA. chague@emory.edu

Life Sciences
|November 12, 2003
PubMed

Insights

Alpha(1)-adrenergic receptors, crucial for bodily functions, have three subtypes with distinct roles. Research is clarifying their unique functions and signaling pathways, despite similarities.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Neuroscience

Background:

  • Alpha(1)-adrenergic receptors are G protein-coupled receptors activated by epinephrine and norepinephrine.
  • Three human subtypes (alpha(1A), alpha(1B), alpha(1D)) exist, sharing homologous transmembrane domains but differing in termini.
  • These receptors control vital functions across numerous organs.

Purpose of the Study:

  • To review recent advances in understanding the alpha(1)-adrenergic receptor subfamily.
  • To highlight the distinct characteristics and emerging roles of the three subtypes.
  • To underscore the ongoing efforts to elucidate their individual functional significance.

Main Methods:

  • Development of genetically modified mice (knockout models) lacking specific receptor subtypes.
  • Investigation of receptor subcellular localization and trafficking dynamics.
  • Identification and characterization of allosteric modulators and protein binding partners.

Main Results:

  • Advances include subtype-specific knockout mice and new data on receptor localization.
  • Evidence points to distinct protein interactions and potential dimerization for alpha(1)-adrenergic receptor subtypes.
  • Growing indications of significant roles in brain function are emerging.

Conclusions:

  • Despite activating the same G(q/11) pathway, alpha(1)-adrenergic receptor subtypes exhibit unique properties.
  • Further research is needed to fully establish the individual functional roles of these non-identical receptor triplets.
  • Understanding these differences is key to deciphering their specific physiological and pathological contributions.

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers01:17

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...